about
Protection against Radiotherapy-Induced Toxicityγ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusNew approaches to radiation protectionMDP: A Deinococcus Mn2+-Decapeptide Complex Protects Mice from Ionizing RadiationThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsSuccinate ester derivative of δ-tocopherol enhances the protective effects against (60)Co γ-ray-induced hematopoietic injury through granulocyte colony-stimulating factor induction in miceMedical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents.THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure.Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndromeCombined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured miceUse of biomarkers for assessing radiation injury and efficacy of countermeasuresPersonalized Radioproteomics: Identification of a Protein Biomarker Signature for Preemptive Rescue by Tocopherol Succinate in CD34(+) Irradiated Progenitor Cells Isolated from a Healthy Control Donor.Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure.Animal models for acute radiation syndrome drug discovery.Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.Nonhuman primates as models for the discovery and development of radiation countermeasures.Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Pharmacological Modulation of Radiation Damage. Does It Exist a Chance for Other Substances than Hematopoietic Growth Factors and Cytokines?Nuclear Countermeasure Activity of TP508 Linked to Restoration of Endothelial Function and Acceleration of DNA RepairBiologics as countermeasures for acute radiation syndrome: where are we now?Pharmacologically induced reversible hypometabolic state mitigates radiation induced lethality in mice.Microbial cells can cooperate to resist high-level chronic ionizing radiation.Whole thorax irradiation of non-human primates induces persistent nuclear damage and gene expression changes in peripheral blood cells.Radioprotective and radiomitigative effects of BP-C2, a novel lignin-derived polyphenolic composition with ammonium molybdate, in two mouse strains exposed to total body irradiation.Podophyllotoxin and rutin in combination prevents oxidative stress mediated cell death and advances revival of mice gastrointestine following lethal radiation injury.Melatonin attenuates 60 Co γ-ray-induced hematopoietic, immunological and gastrointestinal injuries in C57BL/6 male mice.Radiation-induced hematopoietic myelosuppression and genotoxicity get significantly countered by active principles of Podophyllum hexandrum: A study in strain 'A' mice.Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans).
P2860
Q26741273-E0AEB171-4D3A-445B-AE69-942E0C08883CQ26751505-6EC2D137-E3C5-4B90-AB00-C41E520D8BA8Q27005588-1F7B8E4A-B5E9-4D6C-BD45-BB4E7D0EC319Q27330965-CFFC3588-C24E-44AF-B0E7-F990DED9F420Q28548012-28F3493C-DDF0-4434-87CD-900373E4F89AQ28817576-30C168C5-20A3-4B61-8998-617991C9DA18Q28817753-F4596736-0F1F-49E7-AE7D-785660E0C307Q30245600-4B92AC23-17F1-4BBA-A14D-61A4762FF120Q33728050-5FC73C88-1FE0-49FE-8ED4-FDABBD75E623Q34572191-E330842D-742E-45B9-A7A5-E53CDA2CDCD8Q36357104-16DB5209-FE14-4C51-803A-E9F3864BE294Q36357204-04CC0B8C-1310-47F3-9860-5BD826CD9C92Q36519142-0FE9C457-EC31-43CE-9FF4-8D90548925B3Q36802901-357FE075-460F-4BF4-A391-93AB1D0E901EQ37074231-2F235FEA-DACE-4C01-B344-53003C4F793BQ38394740-C69A3A52-E089-4376-88D6-3BC4C63C71FEQ38730028-EF827C0D-FB22-486E-98E8-C75C3A3C4A28Q39261890-AE52A9E4-F0C6-45B2-9E1A-E94EC4F63529Q39391997-2FD1C3D5-63A6-4A3F-A3D9-3571E5511B61Q39398444-AD708640-528A-455C-8A74-DB8BF2EC618FQ39402305-582D5DC5-2EF4-4648-9DD4-91550835696AQ39624107-37D735E1-1245-4D65-B998-B4BDA2789D98Q42687966-443574F7-CFFB-4CC9-991F-47A9DC257FA6Q47107515-C2864A4E-630E-4DA0-A855-8EA5EEF7D1ACQ47300403-DA845B5A-0E49-4535-83EB-F2388DB6E454Q47652418-9A2B4F5B-6CFC-4CB1-816B-5920B6123877Q48101942-E3ABE645-57B0-4ED1-A8A9-79474EDE0EBCQ49691119-3FCB3FDE-D010-4E7C-A28F-E3B3AF9DB3EFQ52881857-2BEBA61C-4985-43AA-AC3A-6188C8722AA4Q53468016-63FAD9CE-6451-42DC-893F-6F3F779313B6Q55177665-BD9B5E68-759B-452D-A420-495D63A220C3
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Radiation countermeasure agents: an update (2011-2014)
@ast
Radiation countermeasure agents: an update (2011-2014)
@en
type
label
Radiation countermeasure agents: an update (2011-2014)
@ast
Radiation countermeasure agents: an update (2011-2014)
@en
prefLabel
Radiation countermeasure agents: an update (2011-2014)
@ast
Radiation countermeasure agents: an update (2011-2014)
@en
P2093
P2860
P1476
Radiation countermeasure agents: an update (2011-2014)
@en
P2093
Patricia L P Romaine
Stephen Y Wise
Thomas M Seed
Victoria L Newman
P2860
P304
P356
10.1517/13543776.2014.964684
P407
P577
2014-10-14T00:00:00Z